Skip to content
DataLookout
Start free
Menu

FACENCT05702476

Marfan Syndrome (MFS) and Facial Dysmorphism: Non-invasive 3D Assessment

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

See at-risk trials from IRCCS Policlinico S. Donato

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 2026 to Jun 2027
    • Eligibility criteria expanded, about 5 words
  2. Primary completion date: Jun 30, 2024 to Jun 2026v4
  3. Primary completion date: Dec 30, 2023 to Jun 30, 2024v3
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Disease Progression
Timeframe: 18 months

Arms and interventions

MFS Adult patients

Patients with clinical and/or gentic diagnosis of MFS older than 18 years

MFS Paediatric patients

Patients with clinical and/or gentic diagnosis of MFS younger than 18 years

Sites

1 site in 1 country

  • IRCCS Policlinico San DonatoSan Donato Milanese, Lombardy, Italy